STO Equity Snapshot

VICO Weekly Equity Report

Vicore Pharma Holding AB (publ)

Interactive chart JSON snapshot
Latest Close 10.58 SEK 12 Jun 2026
1W Return -3.5% latest completed week
4W Return -7.8% short-term follow-through
12W Return 11.6% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
Company Brief

What the company does

Vicore Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden. The company develops Buloxibutid (C21), an orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) that is in Phase II clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF), as well as in Phase I clinical trial for treating pulmonary hypertension. It also developing Almee, an investigational medical device in clinical development that has completed Phase III clinical stage to address the psychological impact of living with pulmonary fibrosis. It has a cooperation …

Snapshot

What the weekly tape is saying

VICO closed the latest completed week at 10.58 SEK. The 4-week return is -7.8% and the 12-week return is 11.6%. Trend Signal is active, Market Dynamics is 0.98. Setup signature: Deep recovery attempt with a 43/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend -0.7%
Volume 1.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 41 Persistence of active Trend Signal over the last year and current streak.
Momentum 42 Blend of 4-week and 12-week follow-through.
Dynamics 100 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 50 Participation compared with the 13-week volume baseline.
Risk Control 27 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
10.65 SEK
Vs Trend Line
-0.7%
Fair Value
12.24 SEK
Vs Fair Value
-13.5%
52W High
14.10 SEK
52W Low
7.35 SEK
Drawdown
-25.0%
Range Position
47.9%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -3.5%
4W -7.8%
12W 11.6%
26W 5.8%
52W 24.2%

Trend read

Active Streak
3 weeks
52W Active Weeks
29
52W Active Breadth
55.8%
Sector Scope
SE Healthcare
Sector Rank
97 of 158
Sector Percentile
38.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.98
4W MD Change
599.3%
Relative Strength
-8.04
4W RS Change
-399.5%
Expectation
Undecided
Probability
46.79%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
3.6M
13W Average
3.0M
52W Average
2.9M
Vs 13W
1.2x
Vs 52W
1.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.5%
52W Volatility
7.5%
Upside Weeks
24
Downside Weeks
28
Downside Breadth
53.8%
Avg Gain / Loss
6.4% / -4.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
STO
Country
SE
Sector
Healthcare
Industry
Biotechnology
Currency
SEK
Market Cap
3.3B

Opportunity signals

  • Trend Signal is active with a 3-week active streak.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 10.58 SEK -3.5% 10.65 SEK 12.24 SEK 0.98 -8.04 3.6M On
5 Jun 2026 10.96 SEK -6.3% 10.63 SEK 12.28 SEK 1.12 -4.85 4.9M On
29 May 2026 11.70 SEK -1.8% 10.61 SEK 12.33 SEK 0.89 0.77 3.7M On
22 May 2026 11.92 SEK 3.8% 10.59 SEK 12.37 SEK 0.30 2.63 2.9M Off
15 May 2026 11.48 SEK 6.9% 10.57 SEK 12.42 SEK -0.20 2.68 3.1M Off
8 May 2026 10.74 SEK 7.6% 10.57 SEK 12.50 SEK -0.72 -4.89 2.2M Off
1 May 2026 9.98 SEK -1.8% 10.60 SEK 12.59 SEK -1.03 -11.12 1.2M Off
24 Apr 2026 10.16 SEK -4.0% 10.69 SEK 12.66 SEK -1.00 -10.78 3.2M Off
17 Apr 2026 10.58 SEK 6.1% 10.77 SEK 12.71 SEK -0.91 -9.36 2.0M Off
10 Apr 2026 9.97 SEK -2.1% 10.76 SEK 12.77 SEK -0.93 -12.30 2.3M Off
3 Apr 2026 10.18 SEK 3.5% 10.79 SEK 12.83 SEK -0.86 -5.91 1.9M Off
27 Mar 2026 9.84 SEK 3.8% 10.86 SEK 12.90 SEK -0.72 -5.59 6.2M Off
20 Mar 2026 9.48 SEK -3.4% 10.92 SEK 12.95 SEK -0.73 -8.78 1.7M Off
13 Mar 2026 9.81 SEK 0.3% 10.97 SEK 12.99 SEK -0.49 -10.23 1.9M Off